Compare EOLS & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EOLS | TG |
|---|---|---|
| Founded | 2012 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.3M | 273.5M |
| IPO Year | 2018 | 1994 |
| Metric | EOLS | TG |
|---|---|---|
| Price | $4.01 | $7.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 123.7K |
| Earning Date | 03-03-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1.23 | ★ 151.06 |
| EPS | N/A | ★ 0.96 |
| Revenue | $297,176,000.00 | ★ $800,821,000.00 |
| Revenue This Year | $13.37 | N/A |
| Revenue Next Year | $17.56 | N/A |
| P/E Ratio | ★ N/A | $7.86 |
| Revenue Growth | ★ 11.61 | 8.29 |
| 52 Week Low | $4.09 | $6.25 |
| 52 Week High | $12.51 | $9.66 |
| Indicator | EOLS | TG |
|---|---|---|
| Relative Strength Index (RSI) | 33.01 | 37.86 |
| Support Level | N/A | $7.30 |
| Resistance Level | $4.99 | $7.64 |
| Average True Range (ATR) | 0.25 | 0.35 |
| MACD | -0.10 | -0.05 |
| Stochastic Oscillator | 2.33 | 27.53 |
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.